HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ji Li Selected Research

isoacteoside

9/2017Isoacteoside, a dihydroxyphenylethyl glycoside, exhibits anti-inflammatory effects through blocking toll-like receptor 4 dimerization.
11/2002Effect of isoverbascoside, a phenylpropanoid glycoside antioxidant, on proliferation and differentiation of human gastric cancer cell.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ji Li Research Topics

Disease

143Neoplasms (Cancer)
10/2022 - 04/2003
37Inflammation (Inflammations)
10/2022 - 09/2004
36Ischemia
01/2021 - 08/2004
30Rosacea (Acne Rosacea)
12/2022 - 11/2016
28Neoplasm Metastasis (Metastasis)
06/2022 - 05/2004
24Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 12/2011
18Hypoxia (Hypoxemia)
07/2022 - 11/2004
18Reperfusion Injury
01/2021 - 01/2008
17Myocardial Ischemia (Ischemic Heart Diseases)
11/2020 - 02/2005
16Infections
01/2022 - 09/2005
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 08/2010
13Obesity
10/2021 - 11/2003
12Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 06/2010
12Adenocarcinoma
05/2022 - 08/2013
11Insulin Resistance
05/2022 - 11/2003
11Adenocarcinoma of Lung
01/2022 - 01/2018
11Pain (Aches)
11/2019 - 09/2004
10Necrosis
01/2022 - 05/2011
10Shock
11/2020 - 06/2012
9Erythema
05/2022 - 02/2019
9Heart Failure
04/2022 - 04/2005
9Ulcerative Colitis
02/2022 - 12/2014
9Carcinogenesis
01/2022 - 08/2013
9Fibrosis (Cirrhosis)
01/2022 - 12/2011
9Melanoma (Melanoma, Malignant)
01/2022 - 05/2004
9Carcinoma (Carcinomatosis)
01/2022 - 12/2011
8Cardiovascular Diseases (Cardiovascular Disease)
07/2022 - 07/2014
8Crohn Disease (Crohn's Disease)
02/2022 - 12/2014
8Disease Progression
01/2022 - 01/2017
8Stomach Neoplasms (Stomach Cancer)
01/2022 - 11/2002
8Breast Neoplasms (Breast Cancer)
11/2021 - 05/2013
7Type 2 Diabetes Mellitus (MODY)
05/2022 - 11/2003
7Stroke (Strokes)
04/2022 - 09/2016
7Myocardial Infarction
04/2022 - 01/2008
7Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2022 - 05/2017
7Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 12/2011
7Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 12/2009
7Acne Vulgaris
04/2021 - 01/2010
7Prostatic Neoplasms (Prostate Cancer)
12/2020 - 08/2010
7Arthritis (Polyarthritis)
11/2020 - 08/2012
6Atherosclerosis
07/2022 - 01/2012
6Alopecia (Baldness)
07/2022 - 12/2012
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2022 - 11/2008
6HIV Infections (HIV Infection)
01/2019 - 01/2015
5Leukemia
03/2022 - 03/2009
5Lung Neoplasms (Lung Cancer)
01/2022 - 12/2015
5Liver Neoplasms (Liver Cancer)
01/2022 - 09/2016
5Parkinson Disease (Parkinson's Disease)
12/2021 - 02/2016

Drug/Important Bio-Agent (IBA)

34Pharmaceutical PreparationsIBA
10/2022 - 12/2008
33Glucose (Dextrose)FDA LinkGeneric
01/2022 - 08/2004
32Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2004
23CytokinesIBA
04/2022 - 03/2008
23Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2010
15Therapeutic UsesIBA
05/2022 - 12/2002
15AMP-Activated Protein KinasesIBA
09/2019 - 11/2004
13Long Noncoding RNAIBA
10/2022 - 01/2018
12MicroRNAs (MicroRNA)IBA
10/2022 - 08/2013
11Biological ProductsIBA
07/2022 - 01/2005
10LigandsIBA
03/2022 - 03/2009
10Phosphotransferases (Kinase)IBA
11/2021 - 10/2005
10Cocaine (Cocaine HCl)IBA
01/2019 - 06/2012
9Interleukin-6 (Interleukin 6)IBA
05/2022 - 04/2008
9Transcription Factors (Transcription Factor)IBA
01/2022 - 03/2009
9RNA (Ribonucleic Acid)IBA
01/2022 - 09/2016
9EnzymesIBA
01/2022 - 05/2004
9Adrenal Cortex Hormones (Corticosteroids)IBA
10/2021 - 12/2013
9DNA (Deoxyribonucleic Acid)IBA
05/2020 - 06/2010
9Messenger RNA (mRNA)IBA
08/2019 - 08/2009
8Reactive Oxygen Species (Oxygen Radicals)IBA
07/2022 - 06/2010
8C-Reactive ProteinIBA
03/2022 - 12/2008
8SteroidsIBA
03/2022 - 11/2015
8AntibodiesIBA
01/2022 - 08/2014
8Insulin (Novolin)FDA Link
01/2022 - 08/2004
8Small Interfering RNA (siRNA)IBA
01/2021 - 08/2008
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2021 - 04/2011
6ChemokinesIBA
05/2022 - 08/2019
6GemcitabineFDA Link
01/2022 - 12/2011
6Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
6LipidsIBA
01/2022 - 09/2008
6CateninsIBA
12/2021 - 03/2015
6Sirtuin 1IBA
01/2021 - 05/2011
6Mechanistic Target of Rapamycin Complex 1IBA
01/2021 - 05/2011
6Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 04/2016
6Caspase 3 (Caspase-3)IBA
07/2020 - 08/2004
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2022 - 01/2007
5Blood Glucose (Blood Sugar)IBA
01/2022 - 02/2010
5Adenosine Triphosphate (ATP)IBA
01/2022 - 02/2005
5Estrogen ReceptorsIBA
11/2021 - 11/2011
5AntioxidantsIBA
07/2021 - 11/2002
5Polysaccharides (Glycans)IBA
07/2021 - 01/2014

Therapy/Procedure

88Therapeutics
07/2022 - 12/2002
20Drug Therapy (Chemotherapy)
05/2022 - 11/2008
15Immunotherapy
05/2022 - 10/2014
10Lasers (Laser)
01/2022 - 06/2012
10Radiotherapy
12/2021 - 07/2011
8Ligation
01/2020 - 01/2008
6Aftercare (After-Treatment)
01/2021 - 03/2007
6Pancreaticoduodenectomy
11/2019 - 08/2009
6Suture Anchors
10/2018 - 01/2016
5Intravenous Injections
01/2022 - 03/2007